A Bibliometric Review on Candida auris of the First Fifteen Years of Research (2009-2023)

Biomed Res Int. 2023 Oct 12:2023:2385018. doi: 10.1155/2023/2385018. eCollection 2023.

Abstract

Introduction: Candida auris is a relatively novel pathogen first described in 2009 in Japan. It has increased its presence worldwide, becoming a public health concern due to its innate resistance to antifungals and outbreak potential.

Methods: We performed a query using the word "Candida auris" from the Scopus database, further performing a bibliometric analysis with the open-source R package Bibliometrix.

Results: 907 original articles were retrieved, allowing us to map the principal authors, papers, journals, and countries involved in this yeast research, as well as analyze current and future trends and the number of published articles.

Conclusion: C. auris will continue to be a pivotal point in fungal resistance research, either for a better understanding of its resistance and pathogenic mechanisms or for developing novel drugs.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Candida auris
  • Candida*
  • Candidiasis* / drug therapy
  • Candidiasis* / epidemiology
  • Candidiasis* / microbiology
  • Disease Outbreaks
  • Humans
  • Microbial Sensitivity Tests
  • Saccharomyces cerevisiae

Substances

  • Antifungal Agents